Arkolith/Insider Trading/GANX/Form 4

Alder Matthias

Chief Executive Officer, DirectorGain Therapeutics, Inc. (GANX) · full profile →Form 4 · filed Dec 22, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$507
Net Open-Market Flow
-$507
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 21, 2023Sell(S)206$2.46$5075K
Dec 20, 2023Option exercise(M)637——5K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 20, 2023Option exercise(M)637—$07K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-059558) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML